Cao Sean Wuxiong, CBDO, reported a transaction classified as exercise at NovaBridge Biosciences involving 235136.000000 shares. Reported holdings after the transaction were 270209.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
Form 4 relationship flags and nearby filing context
Chief Bus. Development Officer
The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer.
Reported securities are represented by 102,233 ADSs
Each restricted stock unit ("RSU") represents a contingent right to receive one ADS.
Reported securities are represented by 45,320 ADSs.
On September 3, 2025, the Reporting Person was granted 408,933 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance v…
On June 22, 2026, the Reporting Person was granted 181,280 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on September 3, 2026 and the balance vesting ratably over the s…
0 other filings
0 recent txs